Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)
Jordan flag Jordan · Delayed Price · Currency is JOD
3.300
0.00 (0.00%)
At close: Apr 23, 2026

ASE:HPIC Income Statement

Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
17.1116.7115.8117.1116.58
Revenue Growth (YoY)
2.39%5.72%-7.61%3.15%0.02%
Cost of Revenue
7.057.455.936.015.39
Gross Profit
10.069.269.8811.0911.19
Selling, General & Admin
6.355.226.366.456.21
Research & Development
0.850.70.660.580.47
Other Operating Expenses
-0.47-0.350.02-0.14-0.05
Operating Expenses
7.125.577.046.896.77
Operating Income
2.943.692.844.24.42
Interest Expense
-0.14-0.15-0.1-0.07-0.09
EBT Excluding Unusual Items
2.813.542.744.144.33
Pretax Income
2.813.542.744.144.33
Income Tax Expense
0.50.450.410.610.69
Net Income
2.313.092.333.533.64
Net Income to Common
2.313.092.333.533.64
Net Income Growth
-25.30%32.73%-34.04%-3.12%3.75%
Shares Outstanding (Basic)
1010101010
Shares Outstanding (Diluted)
1010101010
EPS (Basic)
0.240.330.250.370.38
EPS (Diluted)
0.240.330.250.370.38
EPS Growth
-25.30%32.73%-34.04%-3.12%3.75%
Free Cash Flow
3.171.592.442.233.95
Free Cash Flow Per Share
0.330.170.260.230.42
Dividend Per Share
0.1900.2200.1650.2500.250
Dividend Growth
-13.64%33.33%-34.00%-25.00%
Gross Margin
58.80%55.40%62.51%64.85%67.48%
Operating Margin
17.21%22.09%17.96%24.58%26.66%
Profit Margin
13.49%18.49%14.73%20.63%21.96%
Free Cash Flow Margin
18.50%9.50%15.45%13.07%23.80%
EBITDA
4.164.793.935.265.32
EBITDA Margin
24.33%28.70%24.84%30.73%32.09%
D&A For EBITDA
1.221.11.091.050.9
EBIT
2.943.692.844.24.42
EBIT Margin
17.21%22.09%17.96%24.58%26.66%
Effective Tax Rate
17.72%12.67%15.07%14.68%15.91%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.